United Therapeutics

Sandoz, Liquidia score $137M win against United in years-long generic Remodulin dispute
Fierce Pharma
Mon, 09/16/24 - 10:22 pm
Sandoz
United Therapeutics
generics
PAH
Treprostinil
United Therapeutics starts litigation with FDA over rival Liquidia's drug application
Reuters
Wed, 02/21/24 - 11:13 am
United Therapeutics
FDA
Liquidia
Treprostinil
pulmonary hypertension
United Therapeutics to Acquire Miromatrix Medical
Yahoo Finance
Mon, 10/30/23 - 10:27 am
United Therapeutics
Miromatrix Medical
M&A
bioengineering
Why Shares of MannKind Were Up Wednesday
Motley Fool
Thu, 05/11/23 - 09:56 am
MannKind
earnings
United Therapeutics
Biopharmas left Black and Latinx patients behind in oncology clinical trials, nonprofit says
Fierce Biotech
Thu, 01/5/23 - 10:09 am
clinical trials
clinical trial diversity
oncology
Sanofi
United Therapeutics
Bristol Myers Squibb
Gossamer could put pressure on Merck
EP Vantage
Fri, 11/11/22 - 10:26 am
Merck
Gossamer Bio
PAH
sotatercept
United Therapeutics
ralinepag
United Therapeutics Stops Late-Stage Tyvaso Study In Lung Disease
Yahoo/Benzinga
Wed, 09/21/22 - 10:22 am
United Therapeutics
Tyvaso
COPD
clinical trials
Long after first nod for inhaled Tyvaso, United Therapeutics scraps PhIII in PH with COPD
Endpoints
Tue, 09/20/22 - 10:32 am
Tyvaso
United Therapeutics
PAH
clinical trials
United Therapeutics Provides an Update on Its Organ Printing Programs
BioSpace
Mon, 06/6/22 - 09:55 am
United Therapeutics
organ printing
Medtech
3D Systems
lung scaffolds
Another day, another xenotransplant, as United Therapeutics looks to beat competitors to sci-fi-esque breakthrough
Endpoints
Fri, 01/21/22 - 10:50 am
United Therapeutics
xenotransplants
Revivicor
Medtech
Judge rules HHS' letter enforcing 340B discounts was 'arbitrary'
Beckers Hospital Review
Tue, 11/2/21 - 11:51 pm
HHS
drug pricing
340B
AstraZeneca
Eli Lilly
Novo Nordisk
Sanofi
United Therapeutics
FDA declines to approve United-MannKind's lung disease therapy
Yahoo/Reuters
Mon, 10/18/21 - 10:42 pm
MannKind
United Therapeutics
Tyvaso
FDA
PAH
HHS lines up Novartis, Lilly, AstraZeneca and 3 other drugmakers for fines due to drug discount violations
Endpoints
Fri, 09/24/21 - 12:00 pm
HHS
340B
discounts
Novartis
Eli Lilly
AstraZeneca
Novo Nordisk
Sanofi
United Therapeutics
MannKind and United Snag Priority Review for Pulmonary Hypertension Drug
BioSpace
Wed, 06/16/21 - 11:17 pm
MannKind
United Therapeutics
PAH
PH-ILD
FDA
priority review
Tyvaso
United Therapeutics: FDA Approves Tyvaso For PH-ILD
NASDAQ
Thu, 04/1/21 - 11:41 pm
United Therapeutics
FDA
Tyvaso
PH-ILD
pulmonary hypertension
United axes PAH program Trevyent, once bought for cheap in acquisition of a rival, after FDA feedback
Endpoints
Wed, 03/3/21 - 10:57 am
United Therapeutics
Trevyent
PAH
SteadyMed
Corporate and regulatory developments over the holidays
EP Vantage
Mon, 01/4/21 - 10:20 am
AstraZeneca
Bristol-Myers Squibb
Celltrion
Cullinan Oncology
JNJ
Myovant Sciences
Osmotica Pharmaceuticals
Pfizer
Y-mAbs Therapeutics
United Therapeutics
Zai Lab
With pipeline setbacks mounting, United snares priority voucher for inhaled formulation of PAH med Tyvaso
Endpoints
Mon, 12/28/20 - 10:47 am
United Therapeutics
Tyvaso
priority review voucher
PAH
United Therapeutics Drug Flunks Small Cell Lung Cancer Clinical Trial
Xconomy
Mon, 02/3/20 - 10:34 am
United Therapeutics
clinical trials
Unituxin
small cell lung cancer
Novartis' Sandoz loses bid to break United Therapeutics' exclusive device deal for Remodulin
Fierce Pharma
Thu, 01/30/20 - 09:17 pm
Novartis
Sandoz
United Therapeutics
Remodulin

Pages